Calidar, Inc.

DURHAM, NC · Founded 2022 · Medtech · Private

4D mammography imaging system for breast cancer detection

Claim this profile

Follows are private to you and power your alerts

Updated · calidar.com

Sector
Medtech
Headquarters
DURHAM, NC
Founded
2022
Latest Form D
$271K, Jan 2022
Total capital
$271K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$271K
1 Form D · last Jan 2022
57 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
8 pending

Capital timeline

2022FEDERAL ↑EQUITY ↓Cumulative $271K1st Form D$271K
2022FEDERAL ↑EQUITY ↓Cumulative $271K1st Form D$271K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$271K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Joshua CarpenterExecutive Officer, DirectorNamed in SEC Form D filings
  • Stefan StrykerExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 8
  • PendingSystem And Method For In Vivo Tissue Imaging Using Coded Aperture X-ray Scatter TomographyUSPTOApplication 18856954
  • PendingApparatus And Method For In Vivo Breast Tissue Imaging Using Coded Aperture Xray Scatter TomographyUSPTOApplication 18727521
  • PendingSystem and method for symmetrical coded aperture imaging for increasing the signal to noise ratio of detected electromagnetic signalsUSPTOApplication 63579395
Show all 8 patent records
  • System And Method For In Vivo Tissue Imaging Using Coded Aperture X-ray Scatter TomographyAug 14, 2025 · Application 18856954Pending
  • Apparatus And Method For In Vivo Breast Tissue Imaging Using Coded Aperture Xray Scatter TomographyMar 20, 2025 · Application 18727521Pending
  • System and method for symmetrical coded aperture imaging for increasing the signal to noise ratio of detected electromagnetic signalsApplication 63579395Pending
  • System And Method For In Vivo Tissue Imaging Using Coded Aperture X-ray Scatter TomographyApplication PCTUS2023018682Pending
  • Apparatus And Method For In Vivo Breast Tissue Imaging Using Coded Aperture X-ray Scatter TomographyApplication PCTUS2023060302Pending
  • System And Method For In Vivo Tissue Imaging Using Coded Aperture X-ray Scatter TomographyApplication 63331764Pending
  • System And Method For Symmetrical Coded Aperture Imaging For Increasing The Signal To Noise Ratio Of Detected Electromagnetic SignalsApplication 19514701Pending
  • System And Method For Symmetrical Coded Aperture Imaging For Increasing The Signal To Noise Ratio Of Detected Electromagnetic SignalsApplication PCTUS2024044173Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .